SynopsisThe global market for Hemostasis Valves was valued at US$ 164 million in the year 2024 and is projected to reach a revised size of US$ 264 million by 2031, growing at a CAGR of 7.2% during the forecast period. A hemostasis valve including a collapsible m.....
SynopsisThe global market for Traveler's Diarrhea Therapeutics was valued at US$ 900 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 7.1% during the forecast period. Traveler"s diarrhea (TD) is .....
SynopsisThe global market for Transcriptomics was valued at US$ 4561 million in the year 2024 and is projected to reach a revised size of US$ 8808 million by 2031, growing at a CAGR of 10.0% during the forecast period. Transcriptomic incorporates the exploration.....
SynopsisThe global market for Elderly and Disabled Assistive Devices was valued at US$ 27230 million in the year 2024 and is projected to reach a revised size of US$ 49370 million by 2031, growing at a CAGR of 9.0% during the forecast period. Assistive technolog.....
SynopsisThe global market for Induced Pluripotent Stem Cells (iPSCs) was valued at US$ 128 million in the year 2024 and is projected to reach a revised size of US$ 285 million by 2031, growing at a CAGR of 12.3% during the forecast period. Induced pluripotent st.....
SynopsisThe global market for Low Vision Aids was valued at US$ 553 million in the year 2024 and is projected to reach a revised size of US$ 849 million by 2031, growing at a CAGR of 6.4% during the forecast period. Low vision is a term used to describe the visu.....
SynopsisThe global market for Powered Wheelchairs was valued at US$ 1621 million in the year 2024 and is projected to reach a revised size of US$ 2196 million by 2031, growing at a CAGR of 4.5% during the forecast period. Powered Wheelchair is a motorized wheelc.....
SynopsisThe global market for Cancer Respiratory Biopsy was valued at US$ 350 million in the year 2024 and is projected to reach a revised size of US$ 1251 million by 2031, growing at a CAGR of 20.0% during the forecast period. Cancer respiratory biopsy is a non.....
SynopsisThe global market for Levonorgestrel was valued at US$ 51.2 million in the year 2024 and is projected to reach a revised size of US$ 64.1 million by 2031, growing at a CAGR of 3.3% during the forecast period. Levonorgestrel is a hormonal medication which.....
SynopsisThe global market for Hemoperfusion was valued at US$ 697 million in the year 2024 and is projected to reach a revised size of US$ 2199 million by 2031, growing at a CAGR of 18.1% during the forecast period. Hemoperfusion is a treatment technique in whic.....
